The results of this study showed a decreasing trend of immune checkpoint expression (PD-1, PD-L1, PD-L2, TIM-3, LAG-3 and galectin-9) in two of the three cell lines when treated with cisplatin, oxaliplatin or pemetrexed [ 128 ].
← all excerpts
The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review.
1
—
—